pH-Dependent Conformational Plasticity of Monoclonal Antibodies at the SiO2/Water Interface: Insights from Neutron Reflectivity and Molecular Dynamics
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Investigating the molecular conformations of monoclonal antibodies (mAbs) adsorbed at the solid/liquid interface is crucial for understanding mAb solution stability and advancing the development of mAb-based biosensors. This study examines the pH-dependent conformational plasticity of a human IgG1k mAb, COE-3, at the SiO 2 /water interface under varying pH conditions (pH 5.5 and 9). By integrating neutron reflectivity (NR) and molecular dynamics (MD) simulations, we reveal that the mAb irreversibly deposits onto the interface at pH 5.5, with surface density saturation reached at 20 ppm bulk concentration. At pH 5.5, the adsorbed mAb adopts a stable “flat-on” orientation, while at pH 9, it assumes a more flexible conformation and a “tilted” orientation. This pH-dependent orientation shift is reversible and influenced by the distinct surface charge properties of the Fab and Fc fragments, with the Fc fragment more prone to desorption at higher pH. The root-mean-square deviation (RMSD) analysis further shows that COE-3 maintains structural stability upon adsorption across both pH levels, showing minimal unfolding or denaturation. These findings highlight how pH-dependent electrostatic interactions between mAb fragments and the SiO 2 interface drive conformational adjustments in the intact mAb, offering insights into adsorption-induced aggregation and suggesting pH modulation as a mechanism for controlling biosensor efficiency.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrostatics and Colloid Interactions · Calcium Carbonate Crystallization and Inhibition · Minerals Flotation and Separation Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biological Physics Group, School of Physics and Astronomy, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
Department of Chemistry
Molecular Sciences Research Hub Imperial College
Dosage Form Design and Development, BioPharmaceutical Development, BioPharmaceuticals R&D
AstraZeneca
STFC ISIS Facility, Rutherford Appleton Laboratory
Funding
AstraZeneca · Biotechnology and Biological Sciences Research Council
References (63)
Show source-provided references
1. 10.1038/nri126510.1038/nri1265 ↗
2. Malik B. · 2023
3. 10.1016/j.coph.2018.05.01010.1016/j.coph.2018.05.010 ↗
4. 10.1002/prp2.53510.1002/prp2.535 ↗
5. 10.1002/jps.2301810.1002/jps.23018 ↗
6. 10.1016/j.xphs.2019.10.04110.1016/j.xphs.2019.10.041 ↗
7. 10.1002/jps.2300110.1002/jps.23001 ↗
8. 10.1002/jps.2209710.1002/jps.22097 ↗
9. 10.1002/jps.2153010.1002/jps.21530 ↗
10. 10.1016/j.xphs.2015.10.00310.1016/j.xphs.2015.10.003 ↗
11. 10.1016/j.cis.2010.12.00710.1016/j.cis.2010.12.007 ↗
12. 10.1002/jps.2442910.1002/jps.24429 ↗
13. 10.1002/jps.2435810.1002/jps.24358 ↗
14. 10.1002/btpr.21110.1002/btpr.211 ↗
15. 10.1039/D0SM01870H10.1039/D0SM01870H ↗
16. 10.1039/D3CC04311H10.1039/D3CC04311H ↗
17. 10.1116/1.497843510.1116/1.4978435 ↗
18. 10.1042/EBC2015000210.1042/EBC20150002 ↗
19. 10.1016/j.bios.2014.10.07510.1016/j.bios.2014.10.075 ↗
20. 10.3390/s1809313810.3390/s18093138 ↗
21. 10.3390/molecules2509204710.3390/molecules25092047 ↗
22. 10.1021/la053245410.1021/la0532454 ↗
23. 10.1021/bm070297u10.1021/bm070297u ↗
24. 10.1021/la201245q10.1021/la201245q ↗
25. 10.4161/mabs.2252210.4161/mabs.22522 ↗
26. 10.1016/j.chroma.2017.03.08410.1016/j.chroma.2017.03.084 ↗
27. 10.1021/acsami.7b1333210.1021/acsami.7b13332 ↗
28. 10.1021/acsami.8b1683210.1021/acsami.8b16832 ↗
29. 10.1021/acsami.7b0613110.1021/acsami.7b06131 ↗
30. 10.1021/acs.molpharmaceut.2c0086410.1021/acs.molpharmaceut.2c00864 ↗
31. 10.1021/mp500233410.1021/mp5002334 ↗
32. 10.1021/mp500533c10.1021/mp500533c ↗
33. 10.3390/biom1312170310.3390/biom13121703 ↗
34. 10.1080/00268976.2023.223624810.1080/00268976.2023.2236248 ↗
35. 10.1016/S1389-1723(01)80127-410.1016/S1389-1723(01)80127-4 ↗
36. 10.1016/j.surfin.2024.10487010.1016/j.surfin.2024.104870 ↗
37. 10.1016/j.colsurfb.2008.12.03610.1016/j.colsurfb.2008.12.036 ↗
38. 10.1016/j.colsurfa.2004.05.02610.1016/j.colsurfa.2004.05.026 ↗
39. 10.1073/pnas.95.21.1227110.1073/pnas.95.21.12271 ↗
40. 10.1021/ac102678610.1021/ac1026786 ↗
41. 10.1126/sciadv.abg287310.1126/sciadv.abg2873 ↗
42. 10.1002/jps.2219810.1002/jps.22198 ↗
43. 10.1002/bit.2315510.1002/bit.23155 ↗
44. 10.1149/1.208682510.1149/1.2086825 ↗
45. 10.1021/la403616610.1021/la4036166 ↗
46. 10.1021/acs.molpharmaceut.2c0109910.1021/acs.molpharmaceut.2c01099 ↗
47. 10.1002/bip.1978.36017071110.1002/bip.1978.360170711 ↗
48. 10.1098/rsif.2009.0168.focus10.1098/rsif.2009.0168.focus ↗
49. 10.1016/j.cocis.2007.02.00110.1016/j.cocis.2007.02.001 ↗
50. 10.1016/j.cocis.2019.03.00710.1016/j.cocis.2019.03.007 ↗
51. Lu J. · 2021
52. Liao M. · 2022
53. 10.1016/j.nima.2014.07.02910.1016/j.nima.2014.07.029 ↗
54. 10.1107/S002188980600507310.1107/S0021889806005073 ↗
55. Hughes, A. RasCAL2019, 2019. https://github.com/arwelHughes/RasCAL_2019.
56. 10.1039/c2cp42029e10.1039/c2cp42029e ↗
57. 10.1002/wcms.6610.1002/wcms.66 ↗
58. 10.1038/nmeth.406710.1038/nmeth.4067 ↗
59. 10.1021/la303884610.1021/la3038846 ↗
60. 10.1063/1.44811810.1063/1.448118 ↗
61. 10.1063/1.240842010.1063/1.2408420 ↗
62. 10.1063/1.32869310.1063/1.328693 ↗
63. 10.1002/jcc.54013081210.1002/jcc.540130812 ↗